Fondaparinux for thrombosis prevention after orthopaedic surgery: A revolution?;Fondaparinux en la profilaxis de la trombosis en cirugía ortopédica. θ?Una revolucion?

Medicina Clinica

Volumn 120, Issue 20, 2003, Pages 775-776

  Monreal, Manuel ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; FONDAPARINUX; HEPARIN;

EDITORIAL; GLUCOSE BLOOD LEVEL; HUMAN; ORTHOPEDIC SURGERY; PHLEBOGRAPHY; POSTOPERATIVE THROMBOSIS; POSTTHROMBOSIS SYNDROME; SYMPTOMATOLOGY;

EID: 0038300853     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13048332     Document Type: Editorial

References (15)

1. Eriksson BI, Bauer KA, Lassen MR, Turpie AGG, for the Steering Committee of the Pentasaccharide in Hip Fracture Surgery Study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med 2001;345:1298-304.
2. Bauer KA, Eriksson BI, Lassen MR, Turpie AGG, for the Steering Committee of the Pentasaccharide in Major Knee Surgery Study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med 2001;345: 1305-10.
3. Lassen MR, Bauer KA, Eriksson BI, Turpie AGG, for the European Pentasaccharide Hip Elective Surgery Study (EPHESUS) Steering Committee. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lancet 2002;359;1715-20.
4. Turpie AGG, Bauer KA, Eriksson BI, Lassen MR, for the Pentathlon 2000 Study Steering Committee. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. Lancet 2002;359:1721-6.
5. Turpie AGG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery. A meta-analysis of 4 randomized double-blind studies. Arch Intern Med 2002;162:1833-40.
6. Heit JA. The potential role of fondaparinux as venous thromboembolism prophylaxis after total hip or knee replacement or hip fracture surgery. Arch Intern Med 2002;162:1806-8.
7. Vormfelde SV. Enoxaparin or fondaparinux for thrombosis prevention after orthopaedic surgery. Lancet 2002;360:1701.
8. Hughes SJ. Enoxaparin or fondaparinux for thrombosis prevention after orthopaedic surgery. Lancet 2002;360:1701.
9. Hughes SJ. Fondaparinux requires further study before firm recommendation. Arch Intern Med 2003;163:498.
10. Anónimo. Fondaprinux. No better than LMWH in preventing pulmonary embolism. Prescr Intern 2003;12:3-5.
11. Leclerc JR, Gent M, Hirsch J, Geerts WH, Ginsberg JS. The incidence of symptomatic venous thromboembolism after enoxaparin prophylaxis in lower extremity arthroplasty. A cohort study of 1,984 patients. Chest 1998; 114:115S-8S.
12. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ. Predictors of survival after deep vein thrombosis and pulmonary embolism. A population-based, cohort study. Arch Intern Med 1999;159: 445-51
13. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total or knee replacement: a metaanalysis of the randomised trials, Lancet 2001;358:9-15.
14. Hirsh J. Evidence for the needs of out-of-hospital thrombosis prophylaxis. Chest 1998;114:113S-4S.
15. McNally MA, McAlinden MG, O'Connell BM, Mollan RAB. Postphlebitic syndrome after hip arthroplasty. 43 patients followed at least 5 years. Acta Orthop Scand 1994;65:595-8.